The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)

This publication has 13 references indexed in Scilit:

• Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cells
  Biochemical Pharmacology, 1983
• PATTERNS OF CROSS-RESISTANCE TO THE ANTI-FOLATE DRUGS TRIMETREXATE, METOPRINE, HOMOFOLATE, AND CB3717 IN HUMAN LYMPHOMA AND OSTEO-SARCOMA CELLS RESISTANT TO METHOTREXATE
  1983
• PHARMACOKINETICS OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE FOLLOWING INFUSIONS OF HIGH-DOSE METHOTREXATE
  1982
• Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy
  Cancer Chemotherapy and Pharmacology, 1981
• A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
  Published by Elsevier ,1981
• HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE - PREDICTIVE VALUE OF SERUM METHOTREXATE CONCENTRATIONS AND CORRECTIVE MEASURES TO AVERT TOXICITY
  1977
• 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.
  Journal of Clinical Investigation, 1976
• The nature of experimental error in enzyme kinetic measurments
  Biochemical Journal, 1975
• Normalization in the fitting of data by iterative methods. Application to tracer kinetics and enzyme kinetics
  Biochemical Journal, 1973
• Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion
  Journal of Pharmaceutical Sciences, 1970